Chemical Compound Review:
AC1LAD1Q phenyl3-[(8-benzyl-7,9,9- trioxo-9$l^{6}...
Synonyms:
Acyclonucleoside, phenyl 3-[(3-benzyl-2,2,4-trioxo-2
- Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line. Chu, E., Chu, M.Y., Darnowski, J.W., Chen, Z.H., Pan, B.C., Chu, S.H. Cancer Res. (1992)
- Activity of acyclic 6-(phenylselenenyl)pyrimidine nucleosides against human immunodeficiency viruses in primary lymphocytes. Goudgaon, N.M., Schinazi, R.F. J. Med. Chem. (1991)
- GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells. Marchal, J.A., Prados, J., Melguizo, C., Gómez, J.A., Campos, J., Gallo, M.A., Espinosa, A., Arena, N., Aránega, A. Br. J. Cancer (1999)
- Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources. Drabikowska, A.K., Lissowska, L., Veres, Z., Shugar, D. Biochem. Pharmacol. (1987)
- Synthesis and biological studies of unsaturated acyclonucleoside analogues of S-adenosyl-L-homocysteine hydrolase inhibitors. Hasan, A., Srivastava, P.C. J. Med. Chem. (1992)
- Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties. Harnden, M.R., Jarvest, R.L., Boyd, M.R., Sutton, D., Vere Hodge, R.A. J. Med. Chem. (1989)
- Acyclonucleoside analogue inhibitors of mammalian purine nucleoside phosphorylase. Bzowska, A., Kulikowska, E., Shugar, D., Chen, B.Y., Lindborg, B., Johansson, N.G. Biochem. Pharmacol. (1991)
- A novel synthesis of acyclonucleosides via allylation of 3-[1-(phenylhydrazono)-L-threo-2,3,4-trihydroxybut-1-yl]quinoxalin-2(1H)one. Hamid, H.M. Carbohydr. Res. (2003)
- A study of the influence of newly synthesized acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivatives on deoxythymidine and deoxycytidine kinase activities in human neurofibrosarcoma and ovarian cancer. Modrzejewska, H., Brzezińska, E., Dramiński, M., Zgit-Wróblewska, A., Krzykowska, K., Rozpończyk, E., Greger, J. Acta Biochim. Pol. (2003)
- Calf spleen purine nucleoside phosphorylase: structure of its ternary complex with an N(7)-acycloguanosine inhibitor and a phosphate anion. Luić, M., Koellner, G., Shugar, D., Saenger, W., Bzowska, A. Acta Crystallogr. D Biol. Crystallogr. (2001)
- Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L. Ueno, Y., Ishihara, S., Ito, Y., Kitade, Y. Bioorg. Med. Chem. Lett. (2004)
- Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase. Drabikowska, A.K., Lissowska, L., Draminski, M., Zgit-Wroblewska, A., Shugar, D. Z. Naturforsch., C, J. Biosci. (1987)
- Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics. Liu, G., Men, P., Kenner, G.H., Miller, S.C., Bruenger, F.W. Nucleosides Nucleotides Nucleic Acids (2004)